Past its pain-relieving outcomes, conolidine has demonstrated a good basic safety margin in preclinical toxicology assessments. In contrast to opioids, which often lead to respiratory melancholy at greater doses, conolidine has not generated signs of substantial respiratory suppression. Additionally, behavioral assessments in murine models recommend an absence of drug-seeking https://johnnyc937pmh6.sunderwiki.com/user